TolerogenixX GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.tolerogenixx.com
Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation
Phase 2
Recruiting
- Conditions
- Kidney Transplantation
- Interventions
- Other: Standard of Care
- First Posted Date
- 2022-05-09
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- TolerogenixX GmbH
- Target Recruit Count
- 126
- Registration Number
- NCT05365672
- Locations
- 🇩🇪
Medizinische Klinik mit Schwerpunkt Nephrologie und Internistische Intensivmedizin Charité - Universitätsmedizin Berlin, Berlin, Germany
🇩🇪Universitätsklinikum Hamburg-Eppendorf, Universitäres Transplantations Centrum, Hamburg, Germany
🇩🇪Medizinische Klinik, Innere Medizin X Nephrologie - Nierenzentrum Universitätsklinikum Heidelberg, Heidelberg, Germany
© Copyright 2025. All Rights Reserved by MedPath